Zhang, Bingxin
Zhu, Shuxia
Zheng, Dong
Zhang, Xinyi
Xie, Wenxia
Zhou, Shujuan
Zheng, Sisi
Wang, Quanqiang
Lin, Zhili
Zheng, Ziwei
Chen, Zixing
Lan, Enqing
Cui, Luning
Ying, Hansen
Zhang, Yu
Lin, Xuanru
Zhuang, Qiang
Qian, Honglan
Hu, Xudong
Zhuang, Yan
Zhang, Qianying
Jin, Zhouxiang
Jiang, Songfu
Ma, Yongyong
Funding for this research was provided by:
National Natural Science Foundation of China (82270212)
Natural Science Foundation of Zhejiang Province (LY20H080003)
Wenzhou Municipal Science and Technology Bureau (Y20220716)
Discipline Cluster of Oncology, Wenzhou Medical University (z2-2023023)
Article History
Received: 8 January 2025
Accepted: 9 April 2025
First Online: 31 May 2025
Declarations
:
: This study was approved by the Ethics Committee in Clinical Research of the First Affiliated Hospital of Wenzhou Medical University (protocol code 2021-063), and written informed consent was obtained from all participants.
: All patients in this study provided their consent for publication.
: The authors declare no competing interests.